Docosahexaenoic acid and cognition throughout the lifespan

Nutrients

Volumn 8, Issue 2, 2016, Pages

  Weiser, Michael J ^a   Butt, Christopher M ^a   Mohajeri, M Hasan ^b  

^a DSM NUTRITIONAL PRODUCTS   (United States)

^b DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

Author keywords

Aging; Brain lipids; Comprehension; Development; Learning; Memory; Neurodegeneration; Nutrition; Omega 3 polyunsaturated fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; MEMBRANE RECEPTOR; POLYUNSATURATED FATTY ACID;

ALZHEIMER DISEASE; COGNITION; COGNITIVE AGING; COGNITIVE DEFECT; COMPREHENSION; DEMENTIA; DIETARY INTAKE; GESTATIONAL AGE; INFANCY; INFORMATION PROCESSING; LEARNING; MEMBRANE STRUCTURE; MEMORY CONSOLIDATION; MYELINATION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NEUROTRANSMISSION; REVIEW; SIGNAL TRANSDUCTION; SOCIOECONOMICS; AGING; BRAIN; DRUG EFFECTS; HUMAN; METABOLISM; PHYSIOLOGY;

AGING; BRAIN; COGNITION; DOCOSAHEXAENOIC ACIDS; HUMANS;

EID: 84958546187     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8020099     Document Type: Review

References (339)

1. Bryan, J.; Osendarp, S.; Hughes, D.; Calvaresi, E.; Baghurst, K.; van Klinken, J.W. Nutrients for cognitive development in school-aged children. Nutr. Rev. 2004, 62, 295-306. [CrossRef] [PubMed].
2. Brenna, J.T.; Diau, G.Y. The influence of dietary docosahexaenoic acid and arachidonic acid on central nervous system polyunsaturated fatty acid composition. Prostaglandins Leukot. Essent. Fat. Acids 2007, 77, 247-250. [CrossRef] [PubMed].
3. Rapoport, S.I. In vivo fatty acid incorporation into brain phospholipids in relation to signal transduction and membrane remodeling. Neurochem. Res. 1999, 24, 1403-1415. [CrossRef] [PubMed].
4. Garcia, M.C.; Ward, G.; Ma, Y.C.; Salem, N., Jr.; Kim, H.Y. Effect of docosahexaenoic acid on the synthesis of phosphatidylserine in rat brain in microsomes and C6 glioma cells. J. Neurochem. 1998, 70, 24-30. [CrossRef] [PubMed].
5. Suzuki, H.; Manabe, S.;Wada, O.; Crawford, M.A. Rapid incorporation of docosahexaenoic acid from dietary sources into brain microsomal, synaptosomal and mitochondrial membranes in adult mice. Int. J. Vitam. Nutr. Res. 1997, 67, 272-278. [PubMed].
6. Uauy, R.; Dangour, A.D. Nutrition in brain development and aging: Role of essential fatty acids. Nutr. Rev. 2006, 64, S24-S33. [CrossRef] [PubMed].
7. Haubner, L.; Sullivan, J.; Ashmeade, T.; Saste, M.; Wiener, D.; Carver, J. The effects of maternal dietary docosahexaenoic acid intake on rat pup myelin and the auditory startle response. Dev. Neurosci. 2007, 29, 460-467. [CrossRef] [PubMed].
8. Orr, S.K.; Bazinet, R.P. The emerging role of docosahexaenoic acid in neuroinflammation. Curr. Opin. Investig. Drugs 2008, 9, 735-743. [PubMed].
9. Goustard-Langelier, B.; Guesnet, P.; Durand, G.; Antoine, J.M.; Alessandri, J.M. n-3 and n-6 fatty acid enrichment by dietary fish oil and phospholipid sources in brain cortical areas and nonneural tissues of formula-fed piglets. Lipids 1999, 34, 5-16. [CrossRef] [PubMed].
10. Anderson, V.; Fenwick, T.; Manly, T.; Robertson, I. Attentional skills following traumatic brain injury in childhood: A componential analysis. Brain Inj. 1998, 12, 937-949. [CrossRef] [PubMed].
11. Barkley, R.A. The executive functions and self-regulation: An evolutionary neuropsychological perspective. Neuropsychol. Rev. 2001, 11, 1-29. [CrossRef] [PubMed].
12. Kuratko, C.N.; Barrett, E.C.; Nelson, E.B.; Salem, N. The relationship of docosahexaenoic acid (DHA) with learning and behavior in healthy children: A review. Nutrients 2013, 5, 2777-2810. [CrossRef] [PubMed].
13. Stonehouse, W. Does consumption of LC omega-3 PUFA enhance cognitive performance in healthy school-aged children and throughout adulthood? Evidence from clinical trials. Nutrients 2014, 6, 2730-2758. [CrossRef] [PubMed].
14. Cederholm, T.; Salem, N., Jr.; Palmblad, J. Omega-3 fatty acids in the prevention of cognitive decline in humans. Adv. Nutr. 2013, 4, 672-676. [CrossRef] [PubMed].
15. Joffre, C.; Nadjar, A.; Lebbadi, M.; Calon, F.; Laye, S. n-3 LCPUFA improves cognition: The young, the old and the sick. Prostaglandins Leukot. Essent. Fat. Acids 2014, 91, 1-20. [CrossRef] [PubMed].
16. Salem, N.; Vandal, M.; Calon, F. The benefit of docosahexaenoic acid for the adult brain in aging and dementia. Prostaglandins Leukot. Essent. Fat. Acids 2015, 92, 15-22. [CrossRef] [PubMed].
17. Sprecher, H.; Luthria, D.L.; Mohammed, B.S.; Baykousheva, S.P. Reevaluation of the pathways for the biosynthesis of polyunsaturated fatty acids. J. Lipid Res. 1995, 36, 2471-2477. [PubMed].
18. Emken, E.A.; Adlof, R.O.; Gulley, R.M. Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim. Biophys. Acta 1994, 1213, 277-288. [CrossRef].
19. Barcelo-Coblijn, G.; Murphy, E.J. Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: Benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Prog. Lipid Res. 2009, 48, 355-374. [CrossRef] [PubMed].
20. Brenna, J.T.; Salem, N., Jr.; Sinclair, A.J.; Cunnane, S.C. Alpha-linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot. Essent. Fat. Acids 2009, 80, 85-91. [CrossRef] [PubMed].
21. Salem, N.; Eggersdorfer, M. Is the world supply of omega-3 fatty acids adequate for optimal human nutrition? Curr. Opin. Clin. Nutr. Metab. Care 2015, 18, 147-154. [CrossRef] [PubMed].
22. Birch, E.E.; Carlson, S.E.; Hoffman, D.R.; Fitzgerald-Gustafson, K.M.; Fu, V.L.; Drover, J.R.; Castaneda, Y.S.; Minns, L.; Wheaton, D.K.; Mundy, D.; et al. The diamond (DHA intake and measurement of neural development) study: A double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid. Am. J. Clin. Nutr. 2010, 91, 848-859. [CrossRef] [PubMed].
23. Hoffman, D.R.; Boettcher, J.A.; Diersen-Schade, D.A. Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: A review of randomized controlled trials. Prostaglandins Leukot. Essent. Fat. Acids 2009, 81, 151-158. [CrossRef] [PubMed].
24. Makrides, M. Is there a dietary requirement for DHA in pregnancy? Prostaglandins Leukot. Essent. Fat. Acids 2009, 81, 171-174. [CrossRef] [PubMed].
25. Brenna, J.T.; Varamini, B.; Jensen, R.G.; Diersen-Schade, D.A.; Boettcher, J.A.; Arterburn, L.M. Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am. J. Clin. Nutr. 2007, 85, 1457-1464. [PubMed].
26. Koletzko, B.; Lien, E.; Agostoni, C.; Bohles, H.; Campoy, C.; Cetin, I.; Decsi, T.; Dudenhausen, J.W.; Dupont, C.; Forsyth, S.; et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: Review of current knowledge and consensus recommendations. J. Perinat. Med. 2008, 36, 5-14. [CrossRef] [PubMed].
27. Aranceta, J.; Pérez-Rodrigo, C. Recommended dietary reference intakes, nutritional goals and dietary guidelines for fat and fatty acids: A systematic review. Br. J. Nutr. 2012, 107, S8-S22. [CrossRef] [PubMed].
28. Mosca, L.; Benjamin, E.J.; Berra, K.; Bezanson, J.L.; Dolor, R.J.; Lloyd-Jones, D.M.; Newby, L.K.; Pina, I.L.; Roger, V.L.; Shaw, L.J.; et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: A guideline from the American Heart Association. Circulation 2011, 123, 1243-1262. [CrossRef] [PubMed].
29. World Health Organization; Food and Agriculture Organization of the United Nations. Report of the Joint FAO/WHO Expert Consultation on the Risks and Benefits of Fish Consumption; FAO Fisheries and Aquaculture Report No. 978; WHO: Geneva, Switzerland; FAO: Rome, Italy, 2010; Volume 978, pp. 25-29.
30. Blasbalg, T.L.; Hibbeln, J.R.; Ramsden, C.E.; Majchrzak, S.F.; Rawlings, R.R. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am. J. Clin. Nutr. 2011, 93, 950-962. [CrossRef] [PubMed].
31. Meyer, B.J. Are we consuming enough long chain omega-3 polyunsaturated fatty acids for optimal health? Prostaglandins Leukot. Essent. Fat. Acids 2011, 85, 275-280. [CrossRef] [PubMed].
32. Simopoulos, A.P. Evolutionary aspects of diet: The omega-6/omega-3 ratio and the brain. Mol. Neurobiol. 2011, 44, 203-215. [CrossRef] [PubMed].
33. Broadhurst, C.L.; Cunnane, S.C.; Crawford, M.A. Rift valley lake fish and shellfish provided brain-specific nutrition for early homo. Br. J. Nutr. 1998, 79, 3-21. [CrossRef] [PubMed].
34. Crawford, M.A.; Bloom, M.; Broadhurst, C.L.; Schmidt, W.F.; Cunnane, S.C.; Galli, C.; Gehbremeskel, K.; Linseisen, F.; Lloyd-Smith, J.; Parkington, J. Evidence for the unique function of docosahexaenoic acid during the evolution of the modern hominid brain. Lipids 1999, 34, S39-S47. [CrossRef] [PubMed].
35. Umhau, J.C.; Zhou,W.; Carson, R.E.; Rapoport, S.I.; Polozova, A.; Demar, J.; Hussein, N.; Bhattacharjee, A.K.; Ma, K.; Esposito, G.; et al. Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography. J. Lipid Res. 2009, 50, 1259-1268. [CrossRef] [PubMed].
36. Kawashima, A.; Harada, T.; Imada, K.; Yano, T.; Mizuguchi, K. Eicosapentaenoic acid inhibits interleukin-6 production in interleukin-1beta-stimulated C6 glioma cells through peroxisome proliferator-activated receptor-gamma. Prostaglandins Leukot. Essent. Fat. Acids 2008, 79, 59-65. [CrossRef] [PubMed].
37. Orr, S.K.; Trepanier, M.O.; Bazinet, R.P. n-3 polyunsaturated fatty acids in animal models with neuroinflammation. Prostaglandins Leukot. Essent. Fat. Acids 2013, 88, 97-103. [CrossRef] [PubMed].
38. Chen, C.T.; Liu, Z.; Ouellet, M.; Calon, F.; Bazinet, R.P. Rapid beta-oxidation of eicosapentaenoic acid in mouse brain: An in situ study. Prostaglandins Leukot. Essent. Fat. Acids 2009, 80, 157-163. [CrossRef] [PubMed].
39. Ouellet, M.; Emond, V.; Chen, C.T.; Julien, C.; Bourasset, F.; Oddo, S.; LaFerla, F.; Bazinet, R.P.; Calon, F. Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study. Neurochem. Int. 2009, 55, 476-482. [CrossRef] [PubMed].
40. Chen, C.T.; Bazinet, R.P. Beta-oxidation and rapid metabolism, but not uptake regulate brain eicosapentaenoic acid levels. Prostaglandins Leukot. Essent. Fat. Acids 2015, 92, 33-40. [CrossRef] [PubMed].
41. Arterburn, L.M.; Hall, E.B.; Oken, H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutr. 2006, 83, 1467S-1476S. [PubMed].
42. Chen, C.T.; Domenichiello, A.F.; Trépanier, M.O.; Liu, Z.; Masoodi, M.; Bazinet, R.P. The low levels of eicosapentaenoic acid in rat brain phospholipids are maintained via multiple redundant mechanisms. J. Lipid Res. 2013, 54, 2410-2422. [CrossRef] [PubMed].
43. Kaur, G.; Molero, J.C.; Weisinger, H.S.; Sinclair, A.J. Orally administered [14C] DPA and [14C] DHA are metabolised differently to [14C] EPA in rats. Br. J. Nutr. 2013, 109, 441-448. [CrossRef] [PubMed].
44. Eaton, S.; Bartlett, K.; Pourfarzam, M. Mammalian mitochondrial beta-oxidation. Biochem. J. 1996, 320, 345-357. [CrossRef] [PubMed].
45. Reddy, J.K.; Hashimoto, T. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: An adaptive metabolic system. Annu. Rev. Nutr. 2001, 21, 193-230. [CrossRef] [PubMed].
46. Morse, N.L. Benefits of docosahexaenoic acid, folic acid, vitamin D and iodine on foetal and infant brain development and function following maternal supplementation during pregnancy and lactation. Nutrients 2012, 4, 799-840. [CrossRef] [PubMed].
47. Lin, Y.H.; Llanos, A.; Mena, P.; Uauy, R.; Salem, N., Jr.; Pawlosky, R.J. Compartmental analyses of 2H5-alpha-linolenic acid and CU-eicosapentaenoic acid toward synthesis of plasma labeled 22:6n-3 in newborn term infants. Am. J. Clin. Nutr. 2010, 92, 284-293. [CrossRef] [PubMed].
48. Pawlosky, R.J.; Salem, N., Jr. Perspectives on alcohol consumption: Liver polyunsaturated fatty acids and essential fatty acid metabolism. Alcohol 2004, 34, 27-33. [CrossRef] [PubMed].
49. Plourde, M.; Cunnane, S.C. Extremely limited synthesis of long chain polyunsaturates in adults: Implications for their dietary essentiality and use as supplements. Appl. Physiol. Nutr. Metab. 2007, 32, 619-634. [CrossRef] [PubMed].
50. Egert, S.; Lindenmeier, M.; Harnack, K.; Krome, K.; Erbersdobler, H.F.; Wahrburg, U.; Somoza, V. Margarines fortified with alpha-linolenic acid, eicosapentaenoic acid, or docosahexaenoic acid alter the fatty acid composition of erythrocytes but do not affect the antioxidant status of healthy adults. J. Nutr. 2012, 142, 1638-1644. [CrossRef] [PubMed].
51. Carver, J.; Benford, V.; Han, B.; Cantor, A. The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects. Brain Res. Bull. 2001, 56, 79-85. [CrossRef].
52. Martinez, M. Tissue levels of polyunsaturated fatty acids during early human development. J. Pediatr. 1992, 120, S129-S138. [CrossRef].
53. Bourre, J.M. Effects of nutrients (in food) on the structure and function of the nervous system: Update on dietary requirements for brain. Part 1: Micronutrients. J. Nutr. Health Aging 2006, 10, 377-385. [PubMed].
54. McNamara, R.K.; Carlson, S.E. Role of omega-3 fatty acids in brain development and function: Potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot. Essent. Fat. Acids 2006, 75, 329-349. [CrossRef] [PubMed].
55. Chen, C.T.; Kitson, A.P.; Hopperton, K.E.; Domenichiello, A.F.; Trepanier, M.O.; Lin, L.E.; Ermini, L.; Post, M.; Thies, F.; Bazinet, R.P. Plasma non-esterified docosahexaenoic acid is the major pool supplying the brain. Sci. Rep. 2015, 5, 15791. [CrossRef] [PubMed].
56. DeMar, J.C., Jr.; Ma, K.; Chang, L.; Bell, J.M.; Rapoport, S.I. Alpha-linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. J. Neurochem. 2005, 94, 1063-1076. [CrossRef] [PubMed].
57. Lemaitre-Delaunay, D.; Pachiaudi, C.; Laville, M.; Pousin, J.; Armstrong, M.; Lagarde, M. Blood compartmental metabolism of docosahexaenoic acid (DHA) in humans after ingestion of a single dose of [13C] DHA in phosphatidylcholine. J. Lipid Res. 1999, 40, 1867-1874. [PubMed].
58. Chen, S.; Subbaiah, P.V. Regioisomers of phosphatidylcholine containing DHA and their potential to deliver DHA to the brain: Role of phospholipase specificities. Lipids 2013, 48, 675-686. [CrossRef] [PubMed].
59. Liu, R.Z.; Mita, R.; Beaulieu, M.; Gao, Z.; Godbout, R. Fatty acid binding proteins in brain development and disease. Int. J. Dev. Biol. 2010, 54, 1229-1239. [CrossRef] [PubMed].
60. Pan, Y.; Scanlon, M.J.; Owada, Y.; Yamamoto, Y.; Porter, C.J.H.; Nicolazzo, J.A. Fatty acid-binding protein 5 facilitates the blood-brain barrier transport of docosahexaenoic acid. Mol. Pharm. 2015, 12, 4375-4385. [CrossRef] [PubMed].
61. Vandal, M.; Alata, W.; Tremblay, C.; Rioux-Perreault, C.; Salem, N.; Calon, F.; Plourde, M. Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE 2. J. Neurochem. 2014, 129, 516-526. [CrossRef] [PubMed].
62. Chen, C.T.; Green, J.T.; Orr, S.K.; Bazinet, R.P. Regulation of brain polyunsaturated fatty acid uptake and turnover. Prostaglandins Leukot. Essent. Fat. Acids 2008, 79, 85-91. [CrossRef] [PubMed].
63. Kennedy, E.P.; Weiss, S.B. The function of cytidine coenzymes in the biosynthesis of phospholipides. J. Biol. Chem. 1956, 222, 193-214. [PubMed].
64. Jensen, C.L.; Lapillonne, A. Docosahexaenoic acid and lactation. Prostaglandins Leukot. Essent. Fat. Acids 2009, 81, 175-178. [CrossRef] [PubMed].
65. Simmer, K.; Patole, S.K.; Rao, S.C. Long-chain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst. Rev. 2011. [CrossRef].
66. Chambaz, J.; Ravel, D.; Manier, M.C.; Pepin, D.; Mulliez, N.; Bereziat, G. Essential fatty acids interconversion in the human fetal liver. Biol. Neonate 1985, 47, 136-140. [CrossRef] [PubMed].
67. Innis, S.M. Essential fatty acid transfer and fetal development. Placenta 2005, 26, S70-S75. [CrossRef] [PubMed].
68. Uauy, R.; Mena, P.; Rojas, C. Essential fatty acids in early life: Structural and functional role. Proc. Nutr. Soc. 2000, 59, 3-15. [CrossRef] [PubMed].
69. Grantham-McGregor, S.; Cheung, Y.B.; Cueto, S.; Glewwe, P.; Richter, L.; Strupp, B. Developmental potential in the first 5 years for children in developing countries. Lancet 2007, 369, 60-70. [CrossRef].
70. Farquharson, J.; Cockburn, F.; Patrick, W.A.; Jamieson, E.C.; Logan, R.W. Infant cerebral cortex phospholipid fatty-acid composition and diet. Lancet 1992, 340, 810-813. [CrossRef].
71. Makrides, M.; Neumann, M.; Simmer, K.; Pater, J.; Gibson, R. Are long-chain polyunsaturated fatty acids essential nutrients in infancy? Lancet 1995, 345, 1463-1468. [CrossRef].
72. European Food Safety Authority. Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA J. 2010, 8, 1461.
73. Makrides, M.; Duley, L.; Olsen, S.F. Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. Cochrane Database Syst Rev. 2006, 3. [CrossRef].
74. Szajewska, H.; Horvath, A.; Koletzko, B. Effect of n-3 long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2006, 83, 1337-1344. [PubMed].
75. Horvath, A.; Koletzko, B.; Szajewska, H. Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: A meta-analysis of randomized controlled trials. Br. J. Nutr. 2007, 98, 253-259. [CrossRef] [PubMed].
76. Ramakrishnan, U.; Stein, A.D.; Parra-Cabrera, S.;Wang, M.; Imhoff-Kunsch, B.; Juarez-Marquez, S.; Rivera, J.; Martorell, R. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: Randomized, double-blind, placebo-controlled trial in Mexico. Food Nutr. Bull. 2010, 31, S108-S116. [CrossRef] [PubMed].
77. Hibbeln, J.R.; Davis, J.M.; Steer, C.; Emmett, P.; Rogers, I.; Williams, C.; Golding, J. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): An observational cohort study. Lancet 2007, 369, 578-585. [CrossRef].
78. Jensen, C.L.; Voigt, R.G.; Llorente, A.M.; Peters, S.U.; Prager, T.C.; Zou, Y.L.; Rozelle, J.C.; Turcich, M.R.; Fraley, J.K.; Anderson, R.E.; et al. Effects of early maternal docosahexaenoic acid intake on neuropsychological status and visual acuity at five years of age of breast-fed term infants. J. Pediatr. 2010, 157, 900-905. [CrossRef] [PubMed].
79. Makrides, M.; Gibson, R.A.; McPhee, A.J.; Yelland, L.; Quinlivan, J.; Ryan, P. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: A randomized controlled trial. JAMA 2010, 304, 1675-1683. [CrossRef] [PubMed].
80. Belfort, M.B.; Rifas-Shiman, S.L.; Kleinman, K.P.; Guthrie, L.B.; Bellinger, D.C.; Taveras, E.M.; Gillman, M.W.; Oken, E. Infant feeding and childhood cognition at ages 3 and 7 years: Effects of breastfeeding duration and exclusivity. JAMA Pediatr. 2013, 167, 836-844. [CrossRef] [PubMed].
81. Hoddinott, P.; Tappin, D.;Wright, C. Breast feeding. BMJ 2008, 336, 881-887. [CrossRef] [PubMed].
82. Jensen, C.L.; Voigt, R.G.; Prager, T.C.; Zou, Y.L.; Fraley, J.K.; Rozelle, J.C.; Turcich, M.R.; Llorente, A.M.; Anderson, R.E.; Heird, W.C. Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants. Am. J. Clin. Nutr. 2005, 82, 125-132. [PubMed].
83. Uauy, R.; Hoffman, D.R.; Mena, P.; Llanos, A.; Birch, E.E. Term infant studies of DHA and ara supplementation on neurodevelopment: Results of randomized controlled trials. J. Pediatr. 2003, 143, S17-S25. [CrossRef].
84. Walker, S.P.; Wachs, T.D.; Gardner, J.M.; Lozoff, B.; Wasserman, G.A.; Pollitt, E.; Carter, J.A.; the International Child Development Steering Group. Child development: Risk factors for adverse outcomes in developing countries. Lancet 2007, 369, 145-157. [CrossRef].
85. Hart, S.L.; Boylan, L.M.; Carroll, S.R.; Musick, Y.A.; Kuratko, C.; Border, B.G.; Lampe, R.M. Brief report: Newborn behavior differs with decosahexaenoic acid levels in breast milk. J. Pediatr. Psychol. 2006, 31, 221-226. [CrossRef] [PubMed].
86. Decsi, T.; Campoy, C.; Koletzko, B. Effect of n-3 polyunsaturated fatty acid supplementation in pregnancy: The nuheal trial. Adv. Exp. Med. Biol. 2005, 569, 109-113. [PubMed].
87. Helland, I.B.; Smith, L.; Saarem, K.; Saugstad, O.D.; Drevon, C.A. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 2003, 111, e39-e44. [CrossRef] [PubMed].
88. Boucher, O.; Burden, M.J.; Muckle, G.; Saint-Amour, D.; Ayotte, P.; Dewailly, E.; Nelson, C.A.; Jacobson, S.W.; Jacobson, J.L. Neurophysiologic and neurobehavioral evidence of beneficial effects of prenatal omega-3 fatty acid intake on memory function at school age. Am. J. Clin. Nutr. 2011, 93, 1025-1037. [CrossRef] [PubMed].
89. Innis, S.M. Impact of maternal diet on human milk composition and neurological development of infants. Am. J. Clin. Nutr. 2014, 99, 734S-741S. [CrossRef] [PubMed].
90. Agostoni, C.; Brunetti, I.; Marco, A.D. Polyunsaturated fatty acids in development in breastfed infants human and neurological. Curr. Pediatr. Rev. 2005, 25-30. [CrossRef].
91. Gibson, R.A.; Neumann, M.A.; Makrides, M. Effect of increasing breast milk docosahexaenoic acid on plasma and erythrocyte phospholipid fatty acids and neural indices of exclusively breast fed infants. Eur. J. Clin. Nutr. 1997, 51, 578-584. [CrossRef] [PubMed].
92. Innis, S.M. Dietary (n-3) fatty acids and brain development. J. Nutr. 2007, 137, 855-859. [PubMed].
93. Horta, B.; Bahl, R.; Martines, J.; Victora, C. Evidence on the Long-Term Effects of Breastfeeding; WHO: Geneva, Switzerland, 2007; pp. 1-52.
94. Oddy, W.H.; Kendall, G.E.; Li, J.; Jacoby, P.; Robinson, M.; de Klerk, N.H.; Silburn, S.R.; Zubrick, S.R.; Landau, L.I.; Stanley, F.J. The long-term effects of breastfeeding on child and adolescent mental health: A pregnancy cohort study followed for 14 years. J. Pediatr. 2010, 156, 568-574. [CrossRef] [PubMed].
95. Eilander, A.; Hundscheid, D.C.; Osendarp, S.J.; Transler, C.; Zock, P.L. Effects of n-3 long chain polyunsaturated fatty acid supplementation on visual and cognitive development throughout childhood: A review of human studies. Prostaglandins Leukot. Essent. Fat. Acids 2007, 76, 189-203. [CrossRef] [PubMed].
96. Drover, J.R.; Hoffman, D.R.; Castañeda, Y.S.; Morale, S.E.; Garfield, S.; Wheaton, D.H.; Birch, E.E. Cognitive function in 18-month-old term infants of the diamond study: A randomized, controlled clinical trial with multiple dietary levels of docosahexaenoic acid. Early Hum. Dev. 2011, 87, 223-230. [CrossRef] [PubMed].
97. Meldrum, S.J.; D'Vaz, N.; Simmer, K.; Dunstan, J.A.; Hird, K.; Prescott, S.L. Effects of high-dose fish oil supplementation during early infancy on neurodevelopment and language: A randomised controlled trial. Br. J. Nutr. 2012, 108, 1443-1454. [CrossRef] [PubMed].
98. Birch, E.E.; Garfield, S.; Castañeda, Y.; Hughbanks-Wheaton, D.; Uauy, R.; Hoffman, D. Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula. Early Hum. Dev. 2007, 83, 279-284. [CrossRef] [PubMed].
99. Makrides, M.; Neumann, M.A.; Jeffrey, B.; Lien, E.L.; Gibson, R.A. A randomized trial of different ratios of linoleic to alpha-linolenic acid in the diet of term infants: Effects on visual function and growth. Am. J. Clin. Nutr. 2000, 71, 120-129. [PubMed].
100. Cohen, J.T.; Bellinger, D.C.; Connor,W.E.; Shaywitz, B.A. A quantitative analysis of prenatal intake of n-3 polyunsaturated fatty acids and cognitive development. Am. J. Prev. Med. 2005, 29, 366-374. [CrossRef] [PubMed].
101. Tofail, F.; Kabir, I.; Hamadani, J.D.; Chowdhury, F.; Yesmin, S.; Mehreen, F.; Huda, S.N. Supplementation of fish-oil and soy-oil during pregnancy and psychomotor development of infants. J. Health Popul. Nutr. 2006, 24, 48-56. [PubMed].
102. Dunstan, J.A.; Simmer, K.; Dixon, G.; Prescott, S.L. Cognitive assessment of children at age 2 (1/2) years after maternal fish oil supplementation in pregnancy: A randomised controlled trial. Arch. Dis. Child. Fetal Neonatal Ed. 2008, 93, F45-F50. [CrossRef] [PubMed].
103. Scott, D.T.; Janowsky, J.S.; Carroll, R.E.; Taylor, J.A.; Auestad, N.; Montalto, M.B. Formula supplementation with long-chain polyunsaturated fatty acids: Are there developmental benefits? Pediatrics 1998, 102, E59. [CrossRef] [PubMed].
104. Hoffman, D.R.; Uauy, R. Essentiality of dietary omega 3 fatty acids for premature infants: Plasma and red blood cell fatty acid composition. Lipids 1992, 27, 886-895. [CrossRef] [PubMed].
105. Fewtrell, M.S.; Abbott, R.A.; Kennedy, K.; Singhal, A.; Morley, R.; Caine, E.; Jamieson, C.; Cockburn, F.; Lucas, A. Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants. J. Pediatr. 2004, 144, 471-479. [CrossRef] [PubMed].
106. Clandinin, M.T.; van Aerde, J.E.; Merkel, K.L.; Harris, C.L.; Springer, M.A.; Hansen, J.W.; Diersen-Schade, D.A. Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid. J. Pediatr. 2005, 146, 461-468. [CrossRef] [PubMed].
107. Henriksen, C.; Haugholt, K.; Lindgren, M.; Aurvåg, A.K.; Rønnestad, A.; Grønn, M.; Solberg, R.; Moen, A.; Nakstad, B.; Berge, R.K.; et al. Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid. Pediatrics 2008, 121, 1137-1145. [CrossRef] [PubMed].
108. Makrides, M.; Collins, C.T.; Gibson, R.A. Impact of fatty acid status on growth and neurobehavioural development in humans. Mater. Child Nutr. 2011, 7 (Suppl. 2), 80-88. [CrossRef] [PubMed].
109. Makrides, M.; Gibson, R.A.; McPhee, A.J.; Collins, C.T.; Davis, P.G.; Doyle, L.W.; Simmer, K.; Colditz, P.B.; Morris, S.; Smithers, L.G.; et al. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: A randomized controlled trial. JAMA 2009, 301, 175-182. [CrossRef] [PubMed].
110. Collins, C.T.; Gibson, R.A.; Anderson, P.J.; McPhee, A.J.; Sullivan, T.R.; Gould, J.F.; Ryan, P.; Doyle, L.W.; Davis, P.G.; McMichael, J.E.; et al. Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: A follow-up of a randomised controlled trial. BMJ Open 2015, 5. [CrossRef] [PubMed].
111. Molloy, C.S.; Stokes, S.; Makrides, M.; Collins, C.T.; Anderson, P.J.; Doyle, L.W. Long-term effect of high-dose supplementation with DHA on visual function at school age in children born at <33 wk gestational age: Results from a follow-up of a randomized controlled trial. Am. J. Clin. Nutr. 2016, 103, 268-275. [PubMed].
112. Prentice, A.M.; van der Merwe, L. Impact of fatty acid status on immune function of children in low-income countries. Mater. Child Nutr. 2011, 7 (Suppl. S2), 89-98. [CrossRef] [PubMed].
113. Scholtz, S.A.; Colombo, J.; Carlson, S.E. Clinical overview of effects of dietary long-chain polyunsaturated fatty acids during the perinatal period. Nestle Nutr. Inst. Workshop Ser. 2013, 77, 145-154. [PubMed].
114. Delgado-Noguera, M.F.; Calvache, J.A.; Bonfill Cosp, X.; Kotanidou, E.P.; Galli-Tsinopoulou, A. Supplementation with long chain polyunsaturated fatty acids (LCPUFA) to breastfeeding mothers for improving child growth and development. Cochrane Database Syst. Rev. 2015, 7. [CrossRef].
115. Michaelsen, K.F.; Dewey, K.G.; Perez-Exposito, A.B.; Nurhasan, M.; Lauritzen, L.; Roos, N. Food sources and intake of n-6 and n-3 fatty acids in low-income countries with emphasis on infants, young children (6-24 months), and pregnant and lactating women. Mater. Child Nutr. 2011, 7 (Suppl. 2), 124-140. [CrossRef] [PubMed].
116. Barbarich, B.N.;Willows, N.D.;Wang, L.; Clandinin, M.T. Polyunsaturated fatty acids and anthropometric indices of children in rural China. Eur. J. Clin. Nutr. 2006, 60, 1100-1107. [CrossRef] [PubMed].
117. Yakes, E.A.; Arsenault, J.E.; Islam, M.M.; Hossain, M.B.; Ahmed, T.; German, J.B.; Gillies, L.A.; Rahman, A.S.; Drake, C.; Jamil, K.M.; et al. Intakes and breast-milk concentrations of essential fatty acids are low among Bangladeshi women with 24-48-month-old children. Br. J. Nutr. 2011, 105, 1660-1670. [CrossRef] [PubMed].
118. Huybregts, L.F.; Roberfroid, D.A.; Kolsteren, P.W.; van Camp, J.H. Dietary behaviour, food and nutrient intake of pregnant women in a rural community in Burkina Faso. Mater. Child Nutr. 2009, 5, 211-222. [CrossRef] [PubMed].
119. Mardones, F.; Urrutia, M.T.; Villarroel, L.; Rioseco, A.; Castillo, O.; Rozowski, J.; Tapia, J.L.; Bastias, G.; Bacallao, J.; Rojas, I. Effects of a dairy product fortified with multiple micronutrients and omega-3 fatty acids on birth weight and gestation duration in pregnant Chilean women. Public Health Nutr. 2008, 11, 30-40. [CrossRef] [PubMed].
120. Muthayya, S.; Eilander, A.; Transler, C.; Thomas, T.; van der Knaap, H.C.; Srinivasan, K.; van Klinken, B.J.; Osendarp, S.J.; Kurpad, A.V. Effect of fortification with multiple micronutrients and n-3 fatty acids on growth and cognitive performance in Indian schoolchildren: The champion (children's health and mental performance influenced by optimal nutrition) study. Am. J. Clin. Nutr. 2009, 89, 1766-1775. [CrossRef] [PubMed].
121. Osendarp, S.J.; Baghurst, K.I.; Bryan, J.; Calvaresi, E.; Hughes, D.; Hussaini, M.; Karyadi, S.J.; van Klinken, B.J.; van der Knaap, H.C.; Lukito,W.; et al. Effect of a 12-mo micronutrient intervention on learning and memory in well-nourished and marginally nourished school-aged children: 2 parallel, randomized, placebo-controlled studies in Australia and Indonesia. Am. J. Clin. Nutr. 2007, 86, 1082-1093. [PubMed].
122. Dalton, A.; Wolmarans, P.; Witthuhn, R.C.; van Stuijvenberg, M.E.; Swanevelder, S.A.; Smuts, C.M. A randomised control trial in schoolchildren showed improvement in cognitive function after consuming a bread spread, containing fish flour from a marine source. Prostaglandins Leukot. Essent. Fat. Acids 2009, 80, 143-149. [CrossRef] [PubMed].
123. Stevens, L.J.; Zentall, S.S.; Abate, M.L.; Kuczek, T.; Burgess, J.R. Omega-3 fatty acids in boys with behavior, learning, and health problems. Physiol. Behav. 1996, 59, 915-920. [CrossRef].
124. McNamara, R.K.; Able, J.; Jandacek, R.; Rider, T.; Tso, P.; Eliassen, J.C.; Alfieri, D.; Weber, W.; Jarvis, K.; DelBello, M.P.; et al. Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: A placebo-controlled, dose-ranging, functional magnetic resonance imaging study. Am. J. Clin. Nutr. 2010, 91, 1060-1067. [CrossRef] [PubMed].
125. Richardson, A.J.; Burton, J.R.; Sewell, R.P.; Spreckelsen, T.F.; Montgomery, P. Docosahexaenoic acid for reading, cognition and behavior in children aged 7-9 years: A randomized, controlled trial (the DOLAB study). PLoS ONE 2012, 7, e43909.
126. Brew, B.K.; Toelle, B.G.;Webb, K.L.; Almqvist, C.; Marks, G.B.; Investigators, C. Omega-3 supplementation during the first 5 years of life and later academic performance: A randomised controlled trial. Eur. J. Clin. Nutr. 2015, 69, 419-424. [CrossRef] [PubMed].
127. Lassek, W.D.; Gaulin, S.J.C. Sex differences in the relationship of dietary fatty acids to cognitive measures in American children. Front. Evol. Neurosci. 2011, 3, 5. [CrossRef] [PubMed].
128. Extier, A.; Langelier, B.; Perruchot, M.H.; Guesnet, P.; van Veldhoven, P.P.; Lavialle, M.; Alessandri, J.M. Gender affects liver desaturase expression in a rat model of n-3 fatty acid repletion. J. Nutr. Biochem. 2010, 21, 180-187. [CrossRef] [PubMed].
129. Schram, L.B.; Nielsen, C.J.; Porsgaard, T.; Nielsen, N.S.; Holm, R.; Mu, H. Food matrices affect the bioavailability of (n-3) polyunsaturated fatty acids in a single meal study in humans. Food Res. Int. 2007, 40, 1062-1068. [CrossRef].
130. Ulven, S.M.; Kirkhus, B.; Lamglait, A.; Basu, S.; Elind, E.; Haider, T.; Berge, K.; Vik, H.; Pedersen, J.I. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids 2011, 46, 37-46. [CrossRef] [PubMed].
131. Elvevoll, E.O.; Barstad, H.; Breimo, E.S.; Brox, J.; Eilertsen, K.E.; Lund, T.; Olsen, J.O.; Osterud, B. Enhanced incorporation of n-3 fatty acids from fish compared with fish oils. Lipids 2006, 41, 1109-1114. [CrossRef] [PubMed].
132. Arterburn, L.M.; Oken, H.A.; Hoffman, J.P.; Bailey-Hall, E.; Chung, G.; Rom, D.; Hamersley, J.; McCarthy, D. Bioequivalence of docosahexaenoic acid from different algal oils in capsules and in a DHA -fortified food. Lipids 2007, 42, 1011-1024. [CrossRef] [PubMed].
133. Kuratko, C.N.; Salem, N., Jr. Biomarkers of DHA status. Prostaglandins Leukot. Essent. Fat. Acids 2009, 81, 111-118. [CrossRef] [PubMed].
134. Jernerén, F.; Elshorbagy, A.K.; Oulhaj, A.; Smith, S.M.; Refsum, H.; Smith, A.D. Brain atrophy in cognitively impaired elderly: The importance of long-chain !-3 fatty acids and B vitamin status in a randomized controlled trial. Am. J. Clin. Nutr. 2015, 102, 215-221. [CrossRef] [PubMed].
135. McCann, J.C.; Ames, B.N. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am. J. Clin. Nutr. 2005, 82, 281-295. [PubMed].
136. Fleith, M.; Clandinin, M.T. Dietary pufa for preterm and term infants: Review of clinical studies. Crit. Rev. Food Sci Nutr. 2005, 45, 205-229. [CrossRef] [PubMed].
137. Innis, S.M. Fatty acids and early human development. Early Hum. Dev. 2007, 83, 761-766. [CrossRef] [PubMed].
138. Youdim, K.A.; Martin, A.; Joseph, J.A. Essential fatty acids and the brain: Possible health implications. Int. J. Dev. Neurosci. 2000, 18, 383-399. [CrossRef].
139. De Urquiza, A.M.; Liu, S.; Sjoberg, M.; Zetterstrom, R.H.; Griffiths, W.; Sjovall, J.; Perlmann, T. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 2000, 290, 2140-2144. [CrossRef] [PubMed].
140. Kitajka, K.; Sinclair, A.J.; Weisinger, R.S.; Weisinger, H.S.; Mathai, M.; Jayasooriya, A.P.; Halver, J.E.; Puskas, L.G. Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. Proc. Natl. Acad. Sci. USA 2004, 101, 10931-10936. [CrossRef] [PubMed].
141. Calderon, F.; Kim, H.Y. Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J. Neurochem. 2004, 90, 979-988. [CrossRef] [PubMed].
142. Moriguchi, T.; Greiner, R.S.; Salem, N., Jr. Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J. Neurochem. 2000, 75, 2563-2573. [CrossRef] [PubMed].
143. Lingwood, B.E.; Healy, G.N.; Sullivan, S.M.; Pow, D.V.; Colditz, P.B. MAP2 provides reliable early assessment of neural injury in the newborn piglet model of birth asphyxia. J. Neurosci. Methods 2008, 171, 140-146. [CrossRef] [PubMed].
144. Shaikh, S.R.; Dumaual, A.C.; Castillo, A.; LoCascio, D.; Siddiqui, R.A.; Stillwell,W.;Wassall, S.R. Oleic and docosahexaenoic acid differentially phase separate from lipid raft molecules: A comparative NMR, DSC, AFM, and detergent extraction study. Biophys. J. 2004, 87, 1752-1766. [CrossRef] [PubMed].
145. Stillwell, W.; Shaikh, S.R.; Zerouga, M.; Siddiqui, R.; Wassall, S.R. Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reprod. Nutr. Dev. 2005, 45, 559-579. [CrossRef] [PubMed].
146. Vinson, M.; Rausch, O.; Maycox, P.R.; Prinjha, R.K.; Chapman, D.; Morrow, R.; Harper, A.J.; Dingwall, C.; Walsh, F.S.; Burbidge, S.A.; et al. Lipid rafts mediate the interaction between myelin-associated glycoprotein (MAG) on myelin and MAG-receptors on neurons. Mol. Cell. Neurosci. 2003, 22, 344-352. [CrossRef].
147. Jaworski, J.; Sheng, M. The growing role of mtor in neuronal development and plasticity. Mol. Neurobiol. 2006, 34, 205-219. [CrossRef].
148. Jin, Y.; Sui, H.J.; Dong, Y.; Ding, Q.; Qu, W.H.; Yu, S.X.; Jin, Y.X. Atorvastatin enhances neurite outgrowth in cortical neurons in vitro via up-regulating the Akt/mTOR and Akt/GSK-3beta signaling pathways. Acta Pharmacol. Sin. 2012, 33, 861-872. [CrossRef] [PubMed].
149. Cao, D.; Kevala, K.; Kim, J.; Moon, H.S.; Jun, S.B.; Lovinger, D.; Kim, H.Y. Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function. J. Neurochem. 2009, 111, 510-521. [CrossRef] [PubMed].
150. Darios, F.; Davletov, B. Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3. Nature 2006, 440, 813-817. [CrossRef] [PubMed].
151. Nyaradi, A.; Li, J.; Hickling, S.; Foster, J.; Oddy, W.H. The role of nutrition in children's neurocognitive development, from pregnancy through childhood. Front. Hum. Neurosci. 2013, 7, 97. [CrossRef] [PubMed].
152. Bourre, J.M.; Pascal, G.; Durand, G.; Masson, M.; Dumont, O.; Piciotti, M. Alterations in the fatty acid composition of rat brain cells (neurons, astrocytes, and oligodendrocytes) and of subcellular fractions (myelin and synaptosomes) induced by a diet devoid of n-3 fatty acids. J. Neurochem. 1984, 43, 342-348. [CrossRef] [PubMed].
153. Ikemoto, A.; Ohishi, M.; Sato, Y.; Hata, N.; Misawa, Y.; Fujii, Y.; Okuyama, H. Reversibility of n-3 fatty acid deficiency-induced alterations of learning behavior in the rat: Level of n-6 fatty acids as another critical factor. J. Lipid Res. 2001, 42, 1655-1663. [PubMed].
154. Brenna, J.T. Animal studies of the functional consequences of suboptimal polyunsaturated fatty acid status during pregnancy, lactation and early post-natal life. Mater. Child Nutr. 2011, 7 (Suppl. 2), 59-79. [CrossRef] [PubMed].
155. Diau, G.Y.; Hsieh, A.T.; Sarkadi-Nagy, E.A.; Wijendran, V.; Nathanielsz, P.W.; Brenna, J.T. The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system. BMC Med. 2005, 3, 11. [CrossRef] [PubMed].
156. Luchtman, D.W.; Song, C. Cognitive enhancement by omega-3 fatty acids from child-hood to old age: Findings from animal and clinical studies. Neuropharmacology 2013, 64, 550-565. [CrossRef] [PubMed].
157. Neuringer, M.; Connor,W.E.; Lin, D.S.; Barstad, L.; Luck, S. Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc. Natl. Acad. Sci. USA 1986, 83, 4021-4025. [CrossRef] [PubMed].
158. Champoux, M.; Hibbeln, J.R.; Shannon, C.; Majchrzak, S.; Suomi, S.J.; Salem, N., Jr.; Higley, J.D. Fatty acid formula supplementation and neuromotor development in rhesus monkey neonates. Pediatr. Res. 2002, 51, 273-281. [CrossRef] [PubMed].
159. Greiner, R.S.; Moriguchi, T.; Hutton, A.; Slotnick, B.M.; Salem, N., Jr. Rats with low levels of brain docosahexaenoic acid show impaired performance in olfactory-based and spatial learning tasks. Lipids 1999, 34 (Suppl. 1), S239-S243. [CrossRef] [PubMed].
160. Novak, E.M.; Dyer, R.A.; Innis, S.M. High dietary omega-6 fatty acids contribute to reduced docosahexaenoic acid in the developing brain and inhibit secondary neurite growth. Brain Res. 2008, 1237, 136-145. [CrossRef] [PubMed].
161. Abubakari, A.R.; Naderali, M.M.; Naderali, E.K. Omega-3 fatty acid supplementation and cognitive function: Are smaller dosages more beneficial? Int. J. Gen. Med. 2014, 7, 463-473. [PubMed].
162. Jiao, J.; Li, Q.; Chu, J.; Zeng, W.; Yang, M.; Zhu, S. Effect of n-3 PUFA supplementation on cognitive function throughout the life span from infancy to old age: A systematic review and meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2014, 100, 1422-1436. [CrossRef] [PubMed].
163. Yurko-Mauro, K.; Alexander, D.D.; van Elswyk, M.E. Docosahexaenoic acid and adult memory: A systematic review and meta-analysis. PLoS ONE 2015, 10, e0120391.
164. Muldoon, M.F.; Ryan, C.M.; Sheu, L.; Yao, J.K.; Conklin, S.M.; Manuck, S.B. Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthood. J. Nutr. 2010, 140, 848-853. [CrossRef] [PubMed].
165. Leckie, R.L.; Manuck, S.B.; Bhattacharjee, N.; Muldoon, M.F.; Flory, J.M.; Erickson, K.I. Omega-3 fatty acids moderate effects of physical activity on cognitive function. Neuropsychologia 2014, 59, 103-111. [CrossRef] [PubMed].
166. Erickson, K.I.; Voss, M.W.; Prakash, R.S.; Basak, C.; Szabo, A.; Chaddock, L.; Kim, J.S.; Heo, S.; Alves, H.; White, S.M.; et al. Exercise training increases size of hippocampus and improves memory. Proc. Natl. Acad. Sci. USA 2011, 108, 3017-3022. [CrossRef] [PubMed].
167. Erickson, K.I.; Weinstein, A.M.; Lopez, O.L. Physical activity, brain plasticity, and Alzheimer's disease. Arch. Med. Res. 2012, 43, 615-621. [CrossRef] [PubMed].
168. Rogers, P.J.; Appleton, K.M.; Kessler, D.; Peters, T.J.; Gunnell, D.; Hayward, R.C.; Heatherley, S.V.; Christian, L.M.; McNaughton, S.A.; Ness, A.R. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: A randomised controlled trial. Br. J. Nutr. 2008, 99, 421-431. [CrossRef] [PubMed].
169. Jackson, P.A.; Deary, M.E.; Reay, J.L.; Scholey, A.B.; Kennedy, D.O. No effect of 12 weeks' supplementation with 1 g DHA -rich or EPA-rich fish oil on cognitive function or mood in healthy young adults aged 18-35 years. Br. J. Nutr. 2012, 107, 1232-1243. [CrossRef] [PubMed].
170. Antypa, N.; van der Does, A.J.W.; Smelt, A.H.M.; Rogers, R.D. Omega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers. J. Psychopharmacol. 2009, 23, 831-840. [CrossRef] [PubMed].
171. Karr, J.E.; Grindstaff, T.R.; Alexander, J.E. Omega-3 polyunsaturated fatty acids and cognition in a college-aged population. Exp. Clin. Psychopharmacol. 2012, 20, 236-242. [CrossRef] [PubMed].
172. Stonehouse, W.; Conlon, C.A.; Podd, J.; Hill, S.R.; Minihane, A.M.; Haskell, C.; Kennedy, D. DHA supplementation improved both memory and reaction time in healthy young adults: A randomized controlled trial. Am. J. Clin. Nutr. 2013, 94, 1134-1143. [CrossRef] [PubMed].
173. Duff, S.J.; Hampson, E. A sex difference on a novel spatial working memory task in humans. Brain Cogn. 2001, 47, 470-493. [CrossRef] [PubMed].
174. Halpern, D.F. Mapping cognitive processes onto the brain: Mind the gap. Brain Cogn. 2000, 42, 128-130. [CrossRef] [PubMed].
175. Jaremka, L.M.; Derry, H.M.; Bornstein, R.; Prakash, R.S.; Peng, J.; Belury, M.A.; Andridge, R.R.; Malarkey, W.B.; Kiecolt-Glaser, J.K. Omega-3 supplementation and loneliness-related memory problems. Psychosom. Med. 2014, 76, 650-658. [CrossRef] [PubMed].
176. Services, H. Global Health and Aging; National Institutes of Health: Bethesda, MD, USA, 2011; Volume 1, pp. 273-277.
177. Resnick, S.M.; Pham, D.L.; Kraut, M.A.; Zonderman, A.B.; Davatzikos, C. Longitudinal magnetic resonance imaging studies of older adults: A shrinking brain. J. Neurosci. 2003, 23, 3295-3301. [PubMed].
178. McNamara, R.K.; Liu, Y.; Jandacek, R.; Rider, T.; Tso, P. The aging human orbitofrontal cortex: Decreasing polyunsaturated fatty acid composition and associated increases in lipogenic gene expression and stearoyl-CoA desaturase activity. Prostaglandins Leukot. Essent. Fat. Acids 2008, 78, 293-304. [CrossRef] [PubMed].
179. Andre, A.; Juaneda, P.; Sebedio, J.L.; Chardigny, J.M. Plasmalogen metabolism-related enzymes in rat brain during aging: Influence of n-3 fatty acid intake. Biochimie 2006, 88, 103-111. [CrossRef] [PubMed].
180. Giusto, N.M.; Salvador, G.A.; Castagnet, P.I.; Pasquare, S.J.; de Boschero, M.G.I. Age-associated changes in central nervous system glycerolipid composition and metabolism. Neurochem. Res. 2002, 27, 1513-1523. [CrossRef] [PubMed].
181. Plourde, M.; Chouinard-Watkins, R.; Vandal, M.; Zhang, Y.; Lawrence, P.; Brenna, J.T.; Cunnane, S.C. Plasma incorporation, apparent retroconversion and beta-oxidation of 13c-docosahexaenoic acid in the elderly. Nutr. Metab. 2011, 8, 5. [CrossRef] [PubMed].
182. Conklin, S.M.; Gianaros, P.J.; Brown, S.M.; Yao, J.K.; Hariri, A.R.; Manuck, S.B.; Muldoon, M.F. Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neurosci. Lett. 2007, 421, 209-212. [CrossRef] [PubMed].
183. Raji, C.A.; Erickson, K.I.; Lopez, O.L.; Kuller, L.H.; Gach, H.M.; Thompson, P.M.; Riverol, M.; Becker, J.T. Regular fish consumption and age-related brain gray matter loss. Am. J. Prev. Med. 2014, 47, 444-451. [CrossRef] [PubMed].
184. Masliah, E.; Crews, L.; Hansen, L. Synaptic remodeling during aging and in Alzheimer's disease. J. Alzheimer's Dis. 2006, 9, 91-99.
185. Jorm, A.F.; Jolley, D. The incidence of dementia: A meta-analysis. Neurology 1998, 51, 728-733. [CrossRef] [PubMed].
186. Mohajeri, M.H.; Troesch, B.; Weber, P. Inadequate supply of vitamins and DHA in the elderly: Implications for brain aging and Alzheimer-type dementia. Nutrition 2015, 31, 261-275. [CrossRef] [PubMed].
187. Reiman, E.M.; Quiroz, Y.T.; Fleisher, A.S.; Chen, K.; Velez-Pardo, C.; Jimenez-Del-Rio, M.; Fagan, A.M.; Shah, A.R.; Alvarez, S.; Arbelaez, A.; et al. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: A case-control study. Lancet Neurol. 2012, 11, 1048-1056. [CrossRef].
188. Ellinson, M.; Thomas, J.; Patterson, A. A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly. J. Hum. Nutr. Diet. 2004, 17, 371-383. [CrossRef] [PubMed].
189. Adunsky, A.; Arinzon, Z.; Fidelman, Z.; Krasniansky, I.; Arad, M.; Gepstein, R. Plasma homocysteine levels and cognitive status in long-term stay geriatric patients: A cross-sectional study. Arch. Gerontol. Geriatr. 2005, 40, 129-138. [CrossRef] [PubMed].
190. Terry, R.D. Cell death or synaptic loss in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2000, 59, 1118-1119. [CrossRef] [PubMed].
191. Vida, C.; Gonzalez, E.M.; de la Fuente, M. Increase of oxidation and inflammation in nervous and immune systems with aging and anxiety. Curr. Pharm. Des. 2014, 20, 4656-4678. [CrossRef] [PubMed].
192. Kalmijn, S.; van Boxtel, M.P.J.; Ocke, M.; Verschuren, W.M.M.; Kromhout, D.; Launer, L.J. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 2004, 62, 275-280. [CrossRef] [PubMed].
193. Van Gelder, B.M.; Tijhuis, M.; Kalmijn, S.; Kromhout, D. Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: The Zutphen elderly study. Am. J. Clin. Nutr. 2007, 85, 1142-1147. [PubMed].
194. Eskelinen, M.H.; Ngandu, T.; Helkala, E.L.; Tuomilehto, J.; Nissinen, A.; Soininen, H.; Kivipelto, M. Fat intake at midlife and cognitive impairment later in life: A population-based caide study. Int. J. Geriatr. Psychiatry 2008, 23, 741-747. [CrossRef] [PubMed].
195. Velho, S.; Marques-Vidal, P.; Baptista, F.; Camilo, M.E. Dietary intake adequacy and cognitive function in free-living active elderly: A cross-sectional and short-term prospective study. Clin. Nutr. 2008, 27, 77-86. [CrossRef] [PubMed].
196. González, S.; Huerta, J.M.; Fernández, S.; Patterson, A.M.; Lasheras, C. The relationship between dietary lipids and cognitive performance in an elderly population. Int. J. Food Sci. Nutr. 2010, 61, 217-225. [CrossRef] [PubMed].
197. Gao, Q.; Niti, M.; Feng, L.; Yap, K.B.; Ng, T.P. Omega-3 polyunsaturated fatty acid supplements and cognitive decline: Singapore longitudinal aging studies. J. Nutr. Health Aging 2011, 15, 32-35. [CrossRef] [PubMed].
198. Titova, O.E.; Sjögren, P.; Brooks, S.J.; Kullberg, J.; Ax, E.; Kilander, L.; Riserus, U.; Cederholm, T.; Larsson, E.M.; Johansson, L.; et al. Dietary intake of eicosapentaenoic and docosahexaenoic acids is linked to gray matter volume and cognitive function in elderly. Age 2013, 35, 1495-1505. [CrossRef] [PubMed].
199. Qin, B.; Plassman, B.L.; Edwards, L.J.; Popkin, B.M.; Adair, L.S.; Mendez, M.A. Fish intake is associated with slower cognitive decline in Chinese older adults. J. Nutr. 2014, 144, 1579-1585. [CrossRef] [PubMed].
200. Del Brutto, O.H.; Mera, R.M.; Gillman, J.; Zambrano, M.; Ha, J.E. Oily fish intake and cognitive performance in community-dwelling older adults: The Atahualpa project. J. Community Health 2016, 41, 82-86. [CrossRef] [PubMed].
201. Archer, E.; Pavela, G.; Lavie, C.J. The inadmissibility of what we eat in America and nhanes dietary data in nutrition and obesity research and the scientific formulation of national dietary guidelines. Mayo Clin. Proc. 2015, 90, 911-926. [CrossRef] [PubMed].
202. Ammann, E.M.; Pottala, J.V.; Harris, W.S.; Espeland, M.A.; Wallace, R.; Denburg, N.L.; Carnahan, R.M.; Robinson, J.G. Omega-3 fatty acids and domain-specific cognitive aging: Secondary analyses of data from WHISCA. Neurology 2013, 81, 1484-1491. [CrossRef] [PubMed].
203. Heude, B.; Ducimetiere, P.; Berr, C. Cognitive decline and fatty acid composition of erythrocyte membranes-The EVA study. Am. J. Clin. Nutr. 2003, 77, 803-808. [PubMed].
204. Dullemeijer, C.; Durga, J.; Brouwer, I.A.; van de Rest, O.; Kok, F.J.; Brummer, R.J.M.; van Boxtel, M.P.; Verhoef, P. n-3 fatty acid proportions in plasma and cognitive performance in older adults. Am. J. Clin. Nutr. 2007, 86, 1479-1485. [PubMed].
205. Whalley, L.J.; Deary, I.J.; Starr, J.M.;Wahle, K.W.; Rance, K.A.; Bourne, V.J.; Fox, H.C. n-3 fatty acid erythrocyte membrane content, APOEe4, and cognitive variation: An observational follow-up study in late adulthood. Am. J. Clin. Nutr. 2008, 87, 449-454. [PubMed].
206. Tan, Z.S.; Harris, W.S.; Beiser, a.S.; Au, R.; Himali, J.J.; Debette, S.; Pikula, A.; Decarli, C.; Wolf, P.A.; Vasan, R.S.; et al. Red blood cell !-3 fatty acid levels and markers of accelerated brain aging. Neurology 2012, 78, 658-664. [CrossRef] [PubMed].
207. Baierle, M.; Vencato, P.; Oldenburg, L.; Bordignon, S.; Zibetti, M.; Trentini, C.; Duarte, M.; Veit, J.; Somacal, S.; Emanuelli, T.; et al. Fatty acid status and its relationship to cognitive decline and homocysteine levels in the elderly. Nutrients 2014, 6, 3624-3640. [CrossRef] [PubMed].
208. Otsuka, R.; Tange, C.; Nishita, Y.; Kato, Y.; Imai, T.; Ando, F.; Shimokata, H. Serum docosahexaenoic and eicosapentaenoic acid and risk of cognitive decline over 10 years among elderly Japanese. Eur. J. Clin. Nutr. 2014, 68, 503-509. [CrossRef] [PubMed].
209. Dangour, A.D.; Allen, E.; Elbourne, D.; Fasey, N.; Fletcher, A.E.; Hardy, P.; Holder, G.E.; Knight, R.; Letley, L.; Richards, M.; et al. Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: A randomized, double-blind, controlled trial. Am. J. Clin. Nutr. 2010, 91, 1725-1732. [CrossRef] [PubMed].
210. Van de Rest, O.; Geleijnse, J.M.; Kok, F.J.; van Staveren, W.A.; Dullemeijer, C.; OldeRikkert, M.G.M.; Beekman, A.T.F.; de Groot, C.P.G.M. Effect of fish oil on cognitive performance in older subjects: A randomized, controlled trial. Neurology 2008, 71, 430-438. [CrossRef] [PubMed].
211. Stough, C.; Downey, L.; Silber, B.; Lloyd, J.; Kure, C.; Wesnes, K.; Camfield, D. The effects of 90-day supplementation with the omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population. Neurobiol. Aging 2012, 33, e821-e823. [CrossRef] [PubMed].
212. Johnson, E.J.; Mcdonald, K.; Caldarella, S.M.; Chung, H.Y.; Troen, A.M.; Snodderly, D.M. Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. Nutr. Neurosci. 2008, 11, 75-83. [CrossRef] [PubMed].
213. Yurko-Mauro, K.; McCarthy, D.; Rom, D.; Nelson, E.B.; Ryan, A.S.; Blackwell, A.; Salem, N.; Stedman, M. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimer's Dement. 2010, 6, 456-464. [CrossRef] [PubMed].
214. Vakhapova, V.; Cohen, T.; Richter, Y.; Herzog, Y.; Kam, Y.; Korczyn, A.D. Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in nondemented elderly individuals with memory complaints: Results from an open-label extension study. Dement. Geriatr. Cogn. Disord. 2014, 38, 39-45. [CrossRef] [PubMed].
215. Vakhapova, V.; Cohen, T.; Richter, Y.; Herzog, Y.; Korczyn, A.D. Phosphatidylserine containing !-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: A double-blind placebo-controlled trial. Dement. Geriatr. Cogn. Disord. 2010, 29, 467-474. [CrossRef] [PubMed].
216. Nilsson, A.; Radeborg, K.; Salo, I.; Bjorck, I. Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: A randomized controlled cross-over study. Nutr. J. 2012, 11, 99. [CrossRef] [PubMed].
217. Tokuda, H.; Sueyasu, T.; Kontani, M.; Kawashima, H.; Shibata, H.; Koga, Y. Low doses of long-chain polyunsaturated fatty acids affect cognitive function in elderly Japanese men: A randomized controlled trial. J. Oleo Sci. 2015, 2015, 1-12. [CrossRef] [PubMed].
218. Ito, J. Auditory event-related potentials (ERPs) in healthy subjects and patients with dementia. Jpn. J. Clin. Path. (Rinsho Byori). 1991, 39, 859-864.
219. Strike, S.C.; Carlisle, A.; Gibson, E.L.; Dyall, S.C. A high omega-3 fatty acid multinutrient supplement benefits cognition and mobility in older women: A randomized, double-blind, placebo-controlled pilot study. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2016, 71, 236-242. [CrossRef] [PubMed].
220. Maestre, G.E. Assessing dementia in resource-poor regions. Curr. Neurol. Neurosci. Rep. 2012, 12, 511-519. [CrossRef] [PubMed].
221. Deary, I.J.; Corley, J.; Gow, A.J.; Harris, S.E.; Houlihan, L.M.; Marioni, R.E.; Penke, L.; Rafnsson, S.B.; Starr, J.M. Age-associated cognitive decline. Br. Med. Bull. 2009, 92, 135-152. [CrossRef] [PubMed].
222. Scahill, R.I.; Frost, C.; Jenkins, R.; Whitwell, J.L.; Rossor, M.N.; Fox, N.C. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch. Neurol. 2003, 60, 989-994. [CrossRef] [PubMed].
223. Risacher, S.L.; Saykin, A.J.; West, J.D.; Shen, L.; Firpi, H.A.; McDonald, B.C.; Alzheimer's Disease Neuroimaging Initiative. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr. Alzheimer Res. 2009, 6, 347-361. [CrossRef] [PubMed].
224. Kalpouzos, G.; Eustache, F.; de la Sayette, V.; Viader, F.; Chetelat, G.; Desgranges, B.Working memory and FDG-PET dissociate early and late onset Alzheimer disease patients. J. Neurol. 2005, 252, 548-558. [CrossRef] [PubMed].
225. Landau, S.M.; Harvey, D.; Madison, C.M.; Koeppe, R.A.; Reiman, E.M.; Foster, N.L.; Weiner, M.W.; Jagust,W.J.; the Alzheimer's Disease Neuroimaging Initiative. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol. Aging 2011, 32, 1207-1218. [CrossRef] [PubMed].
226. Nugent, S.; Tremblay, S.; Chen, K.W.; Ayutyanont, N.; Roontiva, A.; Castellano, C.A.; Fortier, M.; Roy, M.; Courchesne-Loyer, A.; Bocti, C.; et al. Brain glucose and acetoacetate metabolism: A comparison of young and older adults. Neurobiol. Aging 2014, 35, 1386-1395. [CrossRef] [PubMed].
227. Hooijmans, C.R.; Pasker-de Jong, P.C.M.; de Vries, R.B.M.; Ritskes-Hoitinga, M. The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: A systematic review and meta-analysis. J. Alzheimer's Dis. 2012, 28, 191-209.
228. Richard, E.; Andrieu, S.; Solomon, A.; Mangialasche, F.; Ahtiluoto, S.; van Charante, E.P.M.; Coley, N.; Fratiglioni, L.; Neely, A.S.; Vellas, B.; et al. Methodological challenges in designing dementia prevention trials-The European dementia prevention initiative (EDPI). J. Neurol. Sci. 2012, 322, 64-70. [CrossRef] [PubMed].
229. Albanese, E.; Dangour, A.D.; Uauy, R.; Acosta, D.; Guerra, M.; Guerra, S.S.G.; Huang, Y.; Jacob, K.S.; Rodriguez, J.L.D.; Noriega, L.H.; et al. Dietary fish and meat intake and dementia in latin America, China, and India: A 10/66 dementia research group population-based study. Am. J. Clin. Nutr. 2009, 90, 392-400. [CrossRef] [PubMed].
230. Barberger-Gateau, P.; Raffaitin, C.; Letenneur, L.; Berr, C.; Tzourio, C.; Dartigues, J.F.; Alpe, A. Dietary patterns and risk of dementia. Neurology 2007, 69, 1921-1930. [CrossRef] [PubMed].
231. Schaefer, E.J.; Bongard, V.; Beiser, A.S.; Lamon-Fava, S.; Robins, S.J.; Au, R.; Tucker, K.L.; Kyle, D.J.; Wilson, P.W.F.;Wolf, P.A. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: The Framingham heart study. Arch. Neurol. 2006, 63, 1545-1550. [CrossRef] [PubMed].
232. Wu, S.; Ding, Y.; Wu, F.; Li, R.; Hou, J.; Mao, P. Omega-3 fatty acids intake and risks of dementia and Alzheimer's disease: A meta-analysis. Neurosci. Biobehav. Rev. 2015, 48, 1-9. [CrossRef] [PubMed].
233. Cherubini, A.; Andres-Lacueva, C.; Martin, A.; Lauretani, F.; Iorio, A.D.; Bartali, B.; Corsi, A.; Bandinelli, S.; Mattson, M.P.; Ferrucci, L. Low plasma n-3 fatty acids and dementia in older persons: The InCHIANTI study. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2007, 62, 1120-1126. [CrossRef].
234. Milte, C.M.; Sinn, N.; Street, S.J.; Buckley, J.D.; Coates, A.M.; Howe, P.R.C. Erythrocyte polyunsaturated fatty acid status, memory, cognition and mood in older adults with mild cognitive impairment and healthy controls. Prostaglandins Leukot. Essent. Fat. Acids 2011, 84, 153-161. [CrossRef] [PubMed].
235. Yin, Y.; Fan, Y.; Lin, F.; Xu, Y.; Zhang, J. Nutrient biomarkers and vascular risk factors in subtypes of mild cognitive impairment: A cross-sectional study. J. Nutr. Health Aging 2015, 19, 39-47. [CrossRef] [PubMed].
236. Terano, T.; Fujishiro, S.; Ban, T.; Yamamoto, K.; Tanaka, T.; Noguchi, Y.; Tamura, Y.; Yazawa, K.; Hirayama, T. Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases. Lipids 1999, 34, S345-S346. [CrossRef] [PubMed].
237. Kotani, S.; Sakaguchi, E.; Warashina, S.; Matsukawa, N.; Ishikura, Y.; Kiso, Y.; Sakakibara, M.; Yoshimoto, T.; Guo, J.; Yamashima, T. Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci. Res. 2006, 56, 159-164. [CrossRef] [PubMed].
238. Chiu, C.C.; Su, K.P.; Cheng, T.C.; Liu, H.C.; Chang, C.J.; Dewey, M.E.; Stewart, R.; Huang, S.Y. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study. Prog. Neuro Psychopharmacol. Biol. Psychiatry 2008, 32, 1538-1544. [CrossRef] [PubMed].
239. Sinn, N.; Milte, C.M.; Street, S.J.; Buckley, J.D.; Coates, A.M.; Petkov, J.; Howe, P.R.C. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: A 6-month randomised controlled trial. Br. J. Nutr. 2012, 107, 1682-1693. [CrossRef] [PubMed].
240. Cazzola, R.; Rondanelli, M.; Faliva, M.; Cestaro, B. Effects of DHA -phospholipids, melatonin and tryptophan supplementation on erythrocyte membrane physico-chemical properties in elderly patients suffering from mild cognitive impairment. Exp. Gerontol. 2012, 47, 974-978. [CrossRef] [PubMed].
241. Mahmoudi, M.; Hedayat, M.; Sharifi, F.; Mirarefin, M.; Nazari, N.; Mehrdad, N.; Ghaderpanahi, M.; Tajalizadekhoob, Y.; Badamchizade, Z.; Larijani, B.; et al. Effect of low dose !-3 poly unsaturated fatty acids on cognitive status among older people: A double-blind randomized placebo-controlled study. J. Diabetes Metab. Disord. 2014, 13, 34. [CrossRef] [PubMed].
242. Ward, A.; Crean, S.; Mercaldi, C.J.; Collins, J.M.; Boyd, D.; Cook, M.N.; Arrighi, H.M. Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: A systematic review and meta-analysis. Neuroepidemiology 2012, 38, 1-17. [CrossRef] [PubMed].
243. Alzheimer's Association. 2014 Alzheimer's disease facts and figures. Alzheimer's Dement. 2014, 10, e47-e92.
244. World Health Organization. Dementia: A public health priority. In Dementia; WHO: Geneva, Switzerland, 2012; p. 112.
245. Kelley, A.S.; McGarry, K.; Gorges, R.; Skinner, J.S. The burden of health care costs for patients with dementia in the last 5 years of life. Ann. Intern. Med. 2015, 163, 729-736. [CrossRef] [PubMed].
246. Cummings, J.L.; Zhong, K. Repackaging FDA-approved drugs for degenerative diseases: Promises and challenges. Expert Rev. Clin. Pharmacol. 2014, 7, 161-165. [CrossRef] [PubMed].
247. Hebert, L.E.;Weuve, J.; Scherr, P.A.; Evans, D.A. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 2013, 80, 1778-1783. [CrossRef] [PubMed].
248. Astarita, G.; Jung, K.M.; Berchtold, N.C.; Nguyen, V.Q.; Gillen, D.L.; Head, E.; Cotman, C.W.; Piomelli, D. Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease. PLoS ONE 2010, 5, e12538. [CrossRef] [PubMed].
249. Igarashi, M.; Ma, K.; Gao, F.; Kim, H.W.; Rapoport, S.I.; Rao, J.S. Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex. J. Alzheimer's Dis. 2011, 24, 507-517.
250. Quinn, J.F.; Raman, R.; Thomas, R.G.; Yurko-Mauro, K.; Nelson, E.B.; van Dyck, C.; Galvin, J.E.; Emond, J.; Jack, C.R., Jr.;Weiner, M.; et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: A randomized trial. JAMA 2010, 304, 1903-1911. [CrossRef] [PubMed].
251. Prasad, M.R.; Lovell, M.A.; Yatin, M.; Dhillon, H.; Markesbery, W.R. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 1998, 23, 81-88. [CrossRef] [PubMed].
252. Soderberg, M.; Edlund, C.; Kristensson, K.; Dallner, G. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 1991, 26, 421-425. [CrossRef] [PubMed].
253. Morris, M.C.; Evans, D.a.; Bienias, J.L.; Tangney, C.C.; Bennett, D.a.; Wilson, R.S.; Aggarwal, N.; Schneider, J. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch. Neurol. 2003, 60, 940-946. [CrossRef] [PubMed].
254. Shatenstein, B.; Kergoat, M.J.; Reid, I. Poor nutrient intakes during 1-year follow-up with community-dwelling older adults with early-stage Alzheimer dementia compared to cognitively intact matched controls. J. Am. Diet. Assoc. 2007, 107, 2091-2099. [CrossRef] [PubMed].
255. Daiello, L.A.; Gongvatana, A.; Dunsiger, S.; Cohen, R.A.; Ott, B.R. Association of fish oil supplement use with preservation of brain volume and cognitive function. Alzheimer's Dement. 2015, 11, 226-235. [CrossRef] [PubMed].
256. Conquer, J.; Tierney, M.; Zecevic, J.; Bettger, W.; Fisher, R. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 2000, 35, 1305-1312. [CrossRef] [PubMed].
257. Tully, A.M.; Roche, H.M.; Doyle, R.; Fallon, C.; Bruce, I.; Lawlor, B.; Coakley, D.; Gibney, M.J. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: A case-control study. Br. J. Nutr. 2003, 89, 483. [CrossRef] [PubMed].
258. Wang,W.; Shinto, L.; Connor,W.E.; Quinn, J.F. Nutritional biomarkers in Alzheimer's disease: The association between carotenoids, n-3 fatty acids, and dementia severity. J. Alzheimer's Dis. 2008, 13, 31-38.
259. Lopez, L.B.; Kritz-Silverstein, D.; Barrett-Connor, E. High dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: The rancho bernardo study. J. Nutr. Health Aging 2011, 15, 25-31. [CrossRef] [PubMed].
260. Phillips, M.A.; Childs, C.E.; Calder, P.C.; Rogers, P.J. Lower omega-3 fatty acid intake and status are associated with poorer cognitive function in older age: A comparison of individuals with and without cognitive impairment and Alzheimer's disease. Nutr. Neurosci. 2012, 15, 271-278. [CrossRef] [PubMed].
261. Freund-Levi, Y.; Basun, H.; Cederholm, T.; Faxen-Irving, G.; Garlind, A.; Grut, M.; Vedin, I.; Palmblad, J.; Wahlund, L.O.; Eriksdotter-Jonhagen, M. Omega-3 supplementation in mild to moderate Alzheimer's disease: Effects on neuropsychiatric symptoms. Int. J. Geriatr. Psychiatry 2008, 23, 161-169. [CrossRef] [PubMed].
262. Freund-Levi, Y.; Eriksdotter-Jonhagen, M.; Cederholm, T.; Basun, H.; Faxen-Irving, G.; Garlind, A.; Vedin, I.; Vessby, B.; Wahlund, L.O.; Palmblad, J. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: Omegad study: A randomized double-blind trial. Arch. Neurol. 2006, 63, 1402-1408. [CrossRef] [PubMed].
263. Eriksdotter, M.; Vedin, I.; Falahati, F.; Freund-Levi, Y.; Hjorth, E.; Faxen-Irving, G.; Wahlund, L.O.; Schultzberg, M.; Basun, H.; Cederholm, T.; et al. Plasma fatty acid profiles in relation to cognition and gender in Alzheimer's disease patients during oral omega-3 fatty acid supplementation: The omegad study. J. Alzheimer's Dis. 2015, 48, 805-812. [CrossRef] [PubMed].
264. Levi, Y.F.; Vedin, I.; Cederholm, T.; Basun, H.; Irving, G.F.; Eriksdotter, M.; Hjorth, E.; Schultzberg, M.; Vessby, B.; Wahlund, L.O.; et al. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: The omegad study. J. Intern. Med. 2014, 275, 428-436. [CrossRef] [PubMed].
265. Connor, J.R.; Menzies, S.L. Relationship of iron to oligodendrocytes and myelination. Glia 1996, 17, 83-93. [CrossRef].
266. Peters, A. Age-related changes in oligodendrocytes in monkey cerebral cortex. J. Comp. Neurol. 1996, 371, 153-163. [CrossRef].
267. Thompson, P.M.; Hayashi, K.M.; de Zubicaray, G.; Janke, A.L.; Rose, S.E.; Semple, J.; Herman, D.; Hong, M.S.; Dittmer, S.S.; Doddrell, D.M.; et al. Dynamics of gray matter loss in Alzheimer's disease. J. Neurosci. 2003, 23, 994-1005. [PubMed].
268. Braak, H.; Braak, E. Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol. 1996, 92, 197-201. [CrossRef] [PubMed].
269. Bartzokis, G. Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol. Aging 2011, 32, 1341-1371. [CrossRef] [PubMed].
270. Beal, M.F. Oxidative damage as an early marker of Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging 2005, 26, 585-586. [CrossRef] [PubMed].
271. Virtanen, J.K.; Siscovick, D.S.; Lemaitre, R.N.; Longstreth, W.T.; Spiegelman, D.; Rimm, E.B.; King, I.B.; Mozaffarian, D. Circulating omega-3 polyunsaturated fatty acids and subclinical brain abnormalities on MRI in older adults: The Cardiovascular Health Study. J. Am. Heart Assoc. 2013, 2. [CrossRef] [PubMed].
272. Vermeer, S.E.; Prins, N.D.; den Heijer, T.; Hofman, A.; Koudstaal, P.J.; Breteler, M.M. Silent brain infarcts and the risk of dementia and cognitive decline. N. Engl. J. Med. 2003, 348, 1215-1222. [CrossRef] [PubMed].
273. Peters, A.; Schweiger, U.; Pellerin, L.; Hubold, C.; Oltmanns, K.M.; Conrad, M.; Schultes, B.; Born, J.; Fehm, H.L. The selfish brain: Competition for energy resources. Neurosci. Biobehav. Rev. 2004, 28, 143-180. [CrossRef] [PubMed].
274. Whitmer, R.A.; Sidney, S.; Selby, J.; Johnston, S.C.; Yaffe, K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 2005, 64, 277-281. [CrossRef] [PubMed].
275. Kalaria, R.N.; Ballard, C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis. Assoc. Disord. 1999, 13 (Suppl. 3), S115-S123. [CrossRef] [PubMed].
276. Roher, A.E.; Debbins, J.P.; Malek-Ahmadi, M.; Chen, K.; Pipe, J.G.; Maze, S.; Belden, C.; Maarouf, C.L.; Thiyyagura, P.; Mo, H.; et al. Cerebral blood flow in Alzheimer's disease. Vasc. Health Risk Manag. 2012, 8, 599-611. [CrossRef] [PubMed].
277. Jackson, P.A.; Reay, J.L.; Scholey, A.B.; Kennedy, D.O. DHA -rich oil modulates the cerebral haemodynamic response to cognitive tasks in healthy young adults: A near ir spectroscopy pilot study. Br. J. Nutr. 2012, 107, 1093-1098. [CrossRef] [PubMed].
278. Beydoun, M.A.; Kaufman, J.S.; Satia, J.A.; Rosamond, W.; Folsom, A.R. Plasma n-3 fatty acids and the risk of cognitive decline in older adults: The atherosclerosis risk in communities study. Am. J. Clin. Nutr. 2007, 85, 1103-1111. [PubMed].
279. Huang, T.; Hu, X.; Khan, N.; Yang, J.; Li, D. Effect of polyunsaturated fatty acids on homocysteine metabolism through regulating the gene expressions involved in methionine metabolism. Sci. World J. 2013, 2013. [CrossRef] [PubMed].
280. Ford, A.H.; Flicker, L.; Alfonso, H.; Hankey, G.J.; Norman, P.E.; van Bockxmeer, F.M.; Almeida, O.P. Plasma homocysteine and MTHFRC677T polymorphism as risk factors for incident dementia. J. Neurol. Neurosurg. Psychiatry 2012, 83, 70-75. [CrossRef] [PubMed].
281. Boneva, N.B.; Yamashima, T. New insights into "GPR40-CREB interaction in adult neurogenesis" specific for primates. Hippocampus 2012, 22, 896-905. [CrossRef] [PubMed].
282. Brand, A.; Schonfeld, E.; Isharel, I.; Yavin, E. Docosahexaenoic acid-dependent iron accumulation in oligodendroglia cells protects from hydrogen peroxide-induced damage. J. Neurochem. 2008, 105, 1325-1335. [CrossRef] [PubMed].
283. Gururajan, A.; van den Buuse, M. Is the mtor-signalling cascade disrupted in schizophrenia? J. Neurochem. 2014, 129, 377-387. [CrossRef] [PubMed].
284. Calon, F.; Lim, G.P.; Morihara, T.; Yang, F.; Ubeda, O.; Salem, N.; Frautschy, S.A.; Cole, G.M. Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease. Eur. J. Neurosci. 2005, 22, 617-626. [CrossRef] [PubMed].
285. Nishikawa, M.; Kimura, S.; Akaike, N. Facilitatory effect of docosahexaenoic acid on N-methyl-D-aspartate response in pyramidal neurones of rat cerebral cortex. J. Physiol. 1994, 475, 83-93. [CrossRef] [PubMed].
286. Calon, F.; Lim, G.P.; Yang, F.; Morihara, T.; Teter, B.; Ubeda, O.; Rostaing, P.; Triller, A.; Salem, N., Jr.; Ashe, K.H.; et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 2004, 43, 633-645. [CrossRef] [PubMed].
287. Dyall, S.C.; Michael, G.J.; Michael-Titus, A.T. Omega-3 fatty acids reverse age-related decreases in nuclear receptors and increase neurogenesis in old rats. J. Neurosci. Res. 2010, 88, 2091-2102. [CrossRef] [PubMed].
288. Maarouf, C.L.; Daugs, I.D.; Kokjohn, T.A.; Walker, D.G.; Hunter, J.M.; Kruchowsky, J.C.; Woltjer, R.; Kaye, J.; Castano, E.M.; Sabbagh, M.N.; et al. Alzheimer's disease and non-demented high pathology control nonagenarians: Comparing and contrasting the biochemistry of cognitively successful aging. PLoS ONE 2011, 6, e27291. [CrossRef] [PubMed].
289. Morimoto, K.; Horio, J.; Satoh, H.; Sue, L.; Beach, T.; Arita, S.; Tooyama, I.; Konishi, Y. Expression profiles of cytokines in the brains of Alzheimer's disease (ad) patients compared to the brains of non-demented patients with and without increasing ad pathology. J. Alzheimer's Dis. 2011, 25, 59-76.
290. Parachikova, A.; Agadjanyan, M.G.; Cribbs, D.H.; Blurton-Jones, M.; Perreau, V.; Rogers, J.; Beach, T.G.; Cotman, C.W. Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol. Aging 2007, 28, 1821-1833. [CrossRef] [PubMed].
291. Cagnin, A.; Brooks, D.J.; Kennedy, A.M.; Gunn, R.N.; Myers, R.; Turkheimer, F.E.; Jones, T.; Banati, R.B. In-vivo measurement of activated microglia in dementia. Lancet 2001, 358, 461-467. [CrossRef].
292. Edison, P.; Archer, H.A.; Gerhard, A.; Hinz, R.; Pavese, N.; Turkheimer, F.E.; Hammers, A.; Tai, Y.F.; Fox, N.; Kennedy, A.; et al. Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol. Dis. 2008, 32, 412-419. [CrossRef] [PubMed].
293. Yokokura, M.; Mori, N.; Yagi, S.; Yoshikawa, E.; Kikuchi, M.; Yoshihara, Y.; Wakuda, T.; Sugihara, G.; Takebayashi, K.; Suda, S.; et al. In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging 2011, 38, 343-351. [CrossRef] [PubMed].
294. Blum-Degen, D.; Muller, T.; Kuhn, W.; Gerlach, M.; Przuntek, H.; Riederer, P. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo parkinson's disease patients. Neurosci. Lett. 1995, 202, 17-20. [CrossRef].
295. Heneka, M.T.; Kummer, M.P.; Latz, E. Innate immune activation in neurodegenerative disease. Nat. Rev. Immunol. 2014, 14, 463-477. [CrossRef] [PubMed].
296. Jia, J.P.; Meng, R.; Sun, Y.X.; Sun, W.J.; Ji, X.M.; Jia, L.F. Cerebrospinal fluid tau, abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia. Neurosci. Lett. 2005, 383, 12-16. [CrossRef] [PubMed].
297. Halle, A.; Hornung, V.; Petzold, G.C.; Stewart, C.R.; Monks, B.G.; Reinheckel, T.; Fitzgerald, K.A.; Latz, E.; Moore, K.J.; Golenbock, D.T. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 2008, 9, 857-865. [CrossRef] [PubMed].
298. Salminen, A.; Ojala, J.; Suuronen, T.; Kaarniranta, K.; Kauppinen, A. Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology. J. Cell. Mol. Med. 2008, 12, 2255-2262. [CrossRef] [PubMed].
299. Hjorth, E.; Zhu, M.; Toro, V.C.; Vedin, I.; Palmblad, J.; Cederholm, T.; Freund-Levi, Y.; Faxen-Irving, G.; Wahlund, L.O.; Basun, H.; et al. Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers. J. Alzheimer's Dis. 2013, 35, 697-713.
300. Krstic, D.; Knuesel, I. Deciphering the mechanism underlying late-onset Alzheimer disease. Nat. Rev. Neurol. 2012, 9, 25-34. [CrossRef] [PubMed].
301. Weiser, M.J.; Mucha, B.; Denheyer, H.; Atkinson, D.; Schanz, N.; Vassiliou, E.; Benno, R.H. Dietary docosahexaenoic acid alleviates autistic-like behaviors resulting from maternal immune activation in mice. Prostaglandins Leukot. Essent. Fat. Acids 2015. [CrossRef] [PubMed].
302. Wang, X.; Hjorth, E.; Vedin, I.; Eriksdotter, M.; Freund-Levi, Y.;Wahlund, L.O.; Cederholm, T.; Palmblad, J.; Schultzberg, M. Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: The OmegAD study. J. Lipid Res. 2015, 56, 674-681. [CrossRef] [PubMed].
303. Serhan, C.N.; Dalli, J.; Colas, R.A.; Winkler, J.W.; Chiang, N. Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. Biochim. Biophys. Acta 2015, 1851, 397-413. [CrossRef] [PubMed].
304. Alfano, C.M.; Imayama, I.; Neuhouser, M.L.; Kiecolt-Glaser, J.K.; Smith, A.W.; Meeske, K.; McTiernan, A.; Bernstein, L.; Baumgartner, K.B.; Ulrich, C.M.; et al. Fatigue, inflammation, and omega-3 and omega-6 fatty acid intake among breast cancer survivors. J. Clin. Oncol. 2012, 30, 1280-1287. [CrossRef] [PubMed].
305. Kiecolt-Glaser, J.K.; Belury, M.A.; Andridge, R.; Malarkey, W.B.; Glaser, R. Omega-3 supplementation lowers inflammation and anxiety in medical students: A randomized controlled trial. Brain Behav. Immun. 2011, 25, 1725-1734. [CrossRef] [PubMed].
306. Bouwens, M.; Bromhaar, M.G.; Jansen, J.; Muller, M.; Afman, L.A. Postprandial dietary lipid-specific effects on human peripheral blood mononuclear cell gene expression profiles. Am. J. Clin. Nutr. 2010, 91, 208-217. [CrossRef] [PubMed].
307. Vedin, I.; Cederholm, T.; Levi, Y.F.; Basun, H.; Garlind, A.; Irving, G.F. Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: The OmegAD study. Am. Soc. Nutr. 2008, 87, 1616-1622.
308. Green, K.N.; Martinez-Coria, H.; Khashwji, H.; Hall, E.B.; Yurko-Mauro, K.A.; Ellis, L.; LaFerla, F.M. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J.Neurosci. 2007, 27, 4385-4395. [CrossRef] [PubMed].
309. Ma, Q.L.; Yang, F.; Rosario, E.R.; Ubeda, O.J.; Beech, W.; Gant, D.J.; Chen, P.P.; Hudspeth, B.; Chen, C.; Zhao, Y.; et al. Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: Suppression by omega-3 fatty acids and curcumin. J. Neurosci. 2009, 29, 9078-9089. [CrossRef] [PubMed].
310. Calon, F. Omega-3 polyunsaturated fatty acids in Alzheimer's disease: Key questions and partial answers. Curr. Alzheimer Res. 2011, 8, 470-478. [CrossRef] [PubMed].
311. Janssen, C.I.F.; Kiliaan, A.J. Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: The influence of LCPUFA on neural development, aging, and neurodegeneration. Prog. Lipid Res. 2014, 53, 1-17. [CrossRef] [PubMed].
312. Krstic, D.; Pfister, S.; Notter, T.; Knuesel, I. Decisive role of reelin signaling during early stages of Alzheimer's disease. Neuroscience 2013, 246, 108-116. [CrossRef] [PubMed].
313. Yavin, E.; Himovichi, E.; Eilam, R. Delayed cell migration in the developing rat brain following maternal omega 3 alpha linolenic acid dietary deficiency. Neuroscience 2009, 162, 1011-1022. [CrossRef] [PubMed].
314. Botella-Lopez, A.; Burgaya, F.; Gavin, R.; Garcia-Ayllon, M.S.; Gomez-Tortosa, E.; Pena-Casanova, J.; Urena, J.M.; del Rio, J.A.; Blesa, R.; Soriano, E.; et al. Reelin expression and glycosylation patterns are altered in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 2006, 103, 5573-5578. [CrossRef] [PubMed].
315. Medhi, B.; Chakrabarty, M. Insulin resistance: An emerging link in Alzheimer's disease. Neurol. Sci. 2013, 34, 1719-1725. [CrossRef] [PubMed].
316. De la Monte, S.M.; Tong, M. Brain metabolic dysfunction at the core of Alzheimer's disease. Biochem. Pharmacol. 2014, 88, 548-559. [CrossRef] [PubMed].
317. Velayudhan, L.; Poppe, M.; Archer, N.; Proitsi, P.; Brown, R.G.; Lovestone, S. Risk of developing dementia in people with diabetes and mild cognitive impairment. Br. J. Psychiatry 2010, 196, 36-40. [CrossRef] [PubMed].
318. Hennebelle, M.; Harbeby, E.; Tremblay, S.; Chouinard-Watkins, R.; Pifferi, F.; Plourde, M.; Guesnet, P.; Cunnane, S.C. Challenges to determining whether DHA can protect against age-related cognitive decline. Clin. Lipidol. 2015, 10, 91-102. [CrossRef].
319. Pifferi, F.; Jouin, M.; Alessandri, J.M.; Haedke, U.; Roux, F.; Perriere, N.; Denis, I.; Lavialle, M.; Guesnet, P. n-3 fatty acids modulate brain glucose transport in endothelial cells of the blood-brain barrier. Prostaglandins Leukot. Essent. Fat. Acids 2007, 77, 279-286. [CrossRef] [PubMed].
320. Pifferi, F.; Jouin, M.; Alessandri, J.M.; Roux, F.; Perriere, N.; Langelier, B.; Lavialle, M.; Cunnane, S.; Guesnet, P. n-3 long-chain fatty acids and regulation of glucose transport in two models of rat brain endothelial cells. Neurochem. Int. 2010, 56, 703-710. [CrossRef] [PubMed].
321. Pifferi, F.; Roux, F.; Langelier, B.; Alessandri, J.M.; Vancassel, S.; Jouin, M.; Lavialle, M.; Guesnet, P. (n-3) polyunsaturated fatty acid deficiency reduces the expression of both isoforms of the brain glucose transporter glut1 in rats. J. Nutr. 2005, 135, 2241-2246. [PubMed].
322. Grimm, M.O.; Kuchenbecker, J.; Grosgen, S.; Burg, V.K.; Hundsdorfer, B.; Rothhaar, T.L.; Friess, P.; deWilde, M.C.; Broersen, L.M.; Penke, B.; et al. Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms. J. Biol. Chem. 2011, 286, 14028-14039. [CrossRef] [PubMed].
323. Martín, V.; Fabelo, N.; Santpere, G.; Puig, B.; Marín, R.; Ferrer, I.; Díaz, M. Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex. J. Alzheimer's Dis. 2010, 19, 489-502.
324. Fabelo, N.; Martin, V.; Marin, R.; Moreno, D.; Ferrer, I.; Diaz, M. Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions. Neurobiol. Aging 2014, 35, 1801-1812. [CrossRef] [PubMed].
325. Hashimoto, M.; Hossain, S.; Katakura, M.; al Mamun, A.; Shido, O. The binding of aβ1-42 to lipid rafts of rbc is enhanced by dietary docosahexaenoic acid in rats: Implicates to Alzheimer's disease. Biochim. Biophys. Acta 2015, 1848, 1402-1409. [CrossRef] [PubMed].
326. Gu, Y.; Schupf, N.; Cosentino, S.A.; Luchsinger, J.A.; Scarmeas, N. Nutrient intake and plasma beta-amyloid. Neurology 2012, 78, 1832-1840. [CrossRef] [PubMed].
327. Flock, M.R.; Skulas-Ray, A.C.; Harris, W.S.; Etherton, T.D.; Fleming, J.A.; Kris-Etherton, P.M. Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: A dose-response randomized controlled trial. J. Am. Heart Assoc. 2013, 2. [CrossRef] [PubMed].
328. Cunnane, S.C.; Schneider, J.A.; Tangney, C.; Tremblay-Mercier, J.; Fortier, M.; Bennett, D.A.; Morris, M.C. Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease. J. Alzheimer's Dis. 2012, 29, 691-697.
329. Chouinard-Watkins, R.; Rioux-Perreault, C.; Fortier, M.; Tremblay-Mercier, J.; Zhang, Y.; Lawrence, P.; Vohl, M.C.; Perron, P.; Lorrain, D.; Brenna, J.T.; et al. Disturbance in uniformly 13c-labelled DHA metabolism in elderly human subjects carrying the apoE "4 allele. Br. J. Nutr. 2013, 110, 1751-1759. [CrossRef] [PubMed].
330. Wu, A.; Noble, E.E.; Tyagi, E.; Ying, Z.; Zhuang, Y.; Gomez-Pinilla, F. Curcumin boosts DHA in the brain: Implications for the prevention of anxiety disorders. Biochim. Biophys. Acta 2015, 1852, 951-961. [CrossRef] [PubMed].
331. Scheltens, P.; Twisk, J.W.R.; Blesa, R.; Scarpini, E.; von Arnim, C.A.F.; Bongers, A.; Harrison, J.; Swinkels, S.H.N.; Stam, C.J.; deWaal, H.; et al. Efficacy of souvenaid in mild Alzheimer's disease: Results from a randomized, controlled trial. J. Alzheimer's Dis. 2012, 31, 225-236.
332. Serhan, C.N. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: An update and role in anti-inflammation and pro-resolution. Prostaglandins Other Lipid Mediat. 2002, 68-69, 433-455. [CrossRef].
333. Serhan, C.N.; Gotlinger, K.; Hong, S.; Arita, M. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: An overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediat. 2004, 73, 155-172. [CrossRef] [PubMed].
334. Ariel, A.; Serhan, C.N. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 2007, 28, 176-183. [CrossRef] [PubMed].
335. Dalli, J.; Winkler, J.W.; Colas, R.A.; Arnardottir, H.; Cheng, C.Y.; Chiang, N.; Petasis, N.A.; Serhan, C.N. Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents. Chem. Biol. 2013, 20, 188-201. [CrossRef] [PubMed].
336. Esiri, M.M. The interplay between inflammation and neurodegeneration in CNS disease. J. Neuroimmunol. 2007, 184, 4-16. [CrossRef] [PubMed].
337. Etminan, M.; Gill, S.; Samii, A. Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: Systematic review and meta-analysis of observational studies. BMJ 2003, 327, 128. [CrossRef] [PubMed].
338. Lehrer, S. Nasal nsaids for Alzheimer's disease. Am. J. Alzheimers Dis. Other Dement. 2014, 29, 401-403. [CrossRef] [PubMed].
339. Lewis, M.D.; Bailes, J. Neuroprotection for the warrior: Dietary supplementation with omega-3 fatty acids. Mil. Med. 2011, 176, 1120-1127. [CrossRef] [PubMed].